The initial phase of chronic myelogenous leukemia (CML) is triggered by con
stitutive protein tyrosine kinase activity bf the chimeric kinase p210(bcr-
abl) (Bcr-Abl). A major substrate of Bcr-Abl was recently identified as the
RasGAP-associated 62 kDa docking protein Dok1. Here, we report complex for
mation between endogenous Dok1 and the SH2 domain-containing phosphatidylin
ositol polyphosphate 5-phosphatase SHIP1 in hematopoietic cells expressing
Bcr-Abl. Expression of Bcr-Abl induced tyrosine phosphorylation of both Dok
1 and SHIP1 and the formation of a Dok1/SHIP1 complex. Tyr(P) SHIP1 was als
o bound to Shc in Bcr-Abl expressing cells. A small amount of Shc/SHIP1/Dok
1 trimolecular complex was detected and this was due to binding of Dok1 to
SHIP1 that was bound to Shc. In contrast, association of Dok1 with SHIP1 or
RasGAP was mutually exclusive. Both the SH2 domain of SHIP1 and the PTB do
main of Dokl were required for complex formation between the two proteins.
Neither the specific activity of SHIP1 as an inositol phosphate 5-phosphata
se nor the subcellular localization of SHIP1 appeared to be altered by tyro
sine phosphorylation. However, the Dok1/SHIP1 complex was only detected in
the cytosolic fraction of Bcr-Abl transformed hematopoietic cells. We propo
se that interaction between Dokl and SHIP1 modulates the ability of these t
wo proteins to interact with other cytosolic binding partners. (C) 2000 Els
evier Science Inc. All rights reserved.